Aug 1, 2019
Hemophilia is a rare blood clotting disorder that affects approximately 20,000 people in the United States and an estimated total of 400,000 people worldwide. The symptoms can range from mild to severe; but keeping it under control often dictates a need for prophylactic or preventative treatment to ensure that bleeding does not become an issue. Bleeding issues often lead to additional medical care, including hospital stays, which means additional costs for employers and the insured. Due to its rarity, the treatments are often extremely expensive. Hemophilia not only an impact upon a person's quality of life, but can be quite the financial...
Read MoreFiled Under: changes in healthcare, Corporate Benefits, hemophilia, high-cost drugs, medications, negotiate medical bills, Specialty Drugs